EZH2-DNMT1-mediated Epigenetic Silencing of Mir-142-3p Promotes Metastasis Through Targeting ZEB2 in Nasopharyngeal Carcinoma

Yingqin Li,Qingmei He,Xin Wen,Xiaohong Hong,Xiaojing Yang,Xinran Tang,Panpan Zhang,Yuan Lei,Ying Sun,Jian Zhang,Yaqin Wang,Jun Ma,Na Liu

DOI: https://doi.org/10.1038/s41418-018-0208-2

IF: 12.067

2018-01-01

Cell Death and Differentiation

Abstract:Human nasopharyngeal carcinoma (NPC) has the highest metastatic rate in head and neck. However, the mechanisms underlying NPC metastasis remain unclear. Here using propensity-score-matched miRNA microarray analysis, miR-142-3p is identified to be the most correlated with distant-metastasis-free survival and downregulated in paraffin-embedded NPC with distant metastasis, which is validated in both internal cohort and external GEO dataset from Canada. miR-142 locus hypermethylation was observed and found to be associated with miR-142-3p downregulation in metastatic NPC. Furthermore, miR-142-3p was epigenetically silenced by EZH2-recruited DNMT1 and suppressed NPC cell metastasis and EMT. Intersecting PCR array gene profiling with bioinformatic prediction, we identify ZEB2 as a direct and functional target of miR-142-3p in NPC. Reversal of miR-142-3p silencing efficiently suppresses NPC cell invasion and metastasis. Moreover, epigenetic miR-142 hypermethylation is correlated with unfavorable prognosis in both training and validation cohorts. This study identifies miR-142-3p as a key suppressive regulator in NPC metastasis and reveals a DNMT1-mediated epigenetic mechanism for miR-142-3p silencing, providing a potential prognostic marker and therapeutic target to combat NPC metastasis.